Pharmacy Times

JULY 22, 2025

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. Overexpansion and staffing issues also play a role.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. Leukemic nonnodal MCL , in contrast, originates from B cells that have undergone germinal center passage with somatic hypermutation in IGHV and that lack SOX11 expression. This subtype is associated with a more indolent course and genomic stability over time.

Pharmacy Technician

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Pharmacy Technician

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Pharmacy Technician

Pharmacy Times

JULY 12, 2025

4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain.

Pharmacy Technician

Pharmacy Times

JUNE 13, 2025

During the session “Collaborative Practice, Statewide Protocols, and Independent Prescriptive Authority: How Pharmacy is Expanding Services to Increase Access to Patients,” Klepser highlighted the importance of moving beyond product dispensing to provide higher-level services, such as immunizations and medication therapy management.

Pharmacy Technician

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. The results confirm nemolizumab’s use in increasing improvements in symptoms, such as itch and skin lesions, with prolonged treatment up to 2 years.

Pharmacy Technician

Pharmacy Times

JULY 25, 2025

These data present a concerning reality in pneumococcal vaccine coverage, one that may have been exacerbated during the COVID-19 pandemic. According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% of individuals ages 19 to 64 at increased risk for pneumococcal disease and 64.0%

Vaccines

Pharmaceutical Technology

AUGUST 13, 2025

In an investor presentation, Insmed stated the drug could generate $5bn in peak sales. The future for Brinsupri is looking bright in its untreaded indication. GlobalData reckons Insemed has a blockbuster on its hands, forecasting sales of $1.7bn by 2033. Around 500,000 people in the US are estimated to have NCFB, according to Insmed.

Packaging

Pharmacy Times

JULY 19, 2025

While the results of this study were presented at the American College of Cardiology meeting in 2023, the completed study results have yet to be published. In a second phase 2 trial using the same dose regimens of baxdrostat in resistant hypertension, placebo-subtracted reductions were not statistically significant.

HIV Treatment and Prevention Agents

Express Pharma

AUGUST 12, 2025

per cent compound annual growth rate from $10.4 The success of immune checkpoint inhibitors (ICIs) and CAR-T cell therapies fueled this initial market growth. New entrants need to target novel immune checkpoints that either improve response rates or offer treatment options for patients previously exposed to checkpoint inhibitors.

Immunization

Pharmacy Times

JUNE 11, 2025

Fertility preservation remains a critical yet often overlooked component of comprehensive cancer care, especially among patients of reproductive age.

Pharmacy Technician

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. AON Pharmacy's interventions saved $1.9 million by withholding shipments due to therapy changes or patient status.

Mail-Order Pharmacies

Pharmacy Times

JUNE 20, 2025

Pharmacy Times: What are some key sessions that will be presented at the upcoming 2025 ADA Scientific Sessions? I'm an endocrine pharmacist and director of education and training and diabetes technology at the Cleveland Clinic. Isaacs : I am so excited for the ADA Scientific Sessions. It is my favorite meeting of the entire year.

Diabetes

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting. Pharmacy Times : What challenges currently exist in the treatment of cutaneous malignancies?

Pharmacy Technician

Pharmacy Times

JUNE 12, 2025

The session, which was entitled “Decoding the Logic: An Overview of Biologics and Biosimilars,” described clinical applications and economic impacts associated with biologics and biosimilars over the last 10 to 15 years, as well as outlined what skills effectively contribute to their management and understanding.

Biosimilars

Pharmacy Times

JULY 22, 2025

When you are enjoyable to work with, reliable, organized, and do impactful work, your name often comes up in spaces where you’re not present, opening doors to new partnerships. Strong collaborations lead to opportunities. It’s a cycle of trust and shared success, and I’ve been fortunate to benefit from and contribute to it.

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

Alixorexton presents as a hopeful, potentially paradigm-shifting treatment for this population. OX2Rs play a critical role in the maintenance of wakefulness in patients with NT1, which is characterized by the loss of orexin-producing neurons in cerebrospinal fluid.

Pharmacy Technician

Pharmacy Times

AUGUST 2, 2025

Role of PCP Counseling for Observers Fasting may present risks to post-metabolic and bariatric surgery (MBS) patients. About the Author Amy C. Nieto is a 2026 PharmD Candidate at the University of Connecticut School of Pharmacy in Storrs, CT.

Diabetes

Pharmacy Times

JUNE 23, 2025

Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. If the request doesn’t come in, all 505(b)(2) drugs will be considered nontherapeutically equivalent and therefore get their own J-code. That’s the system we are headed into very rapidly.” REFERENCE Soefje SA.

Pharmacy Technician

Pharmacy Times

JULY 4, 2025

Patients with inflammatory conditions achieved similar clinical outcomes after switching from the reference adalimumab (Humira; AbbVie) to a biosimilar, according to real-world data presented at the 2025 American Society of Health-System Pharmacists Pharmacy Futures Meeting.

Biosimilars

Pharmacy Times

JULY 23, 2025

Understanding and addressing these emotional barriers may present an opportunity to improve adherence and long-term engagement. For patients beginning treatment with immunology biologics or other specialty medications, the transition can be daunting, involving new routines, adverse effect concerns, and evolving perceptions of illness.

Specialty Pharmacies

Pharmacy Times

JUNE 26, 2025

The findings, published in The New England Journal of Medicine and presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, demonstrated that 10 of the 12 treated individuals no longer needed insulin treatment in a 1-year follow-up.

Diabetes

Pharmacy Times

JULY 31, 2025

If a patient presents with pneumococcal disease, conducting medication reconciliation and ensuring all medications a patient is taking are not negatively contributing to their disease is critical.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

trillion economic impact in 2020. trillion economic impact in 2020. trillion economic impact in 2020. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk.

Pharmacy Technician

Pharmacy Times

JULY 2, 2025

Ototoxicity, presenting as tinnitus, hearing loss, dizziness, or vertigo, could occur and can be reversible or permanent. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.

Pharmacy Technician

Pharmacy Times

AUGUST 6, 2025

These data were presented at the 2025 American Academy of Neurology (AAN) Annual Meeting. 2,3 According to the data presented at the AAN session, fremanezumab was observed to significantly reduce monthly migraine days compared with placebo (–2.5 vs –1.4; P =.0210).

Pharmacy Technician

Pharmacy Times

JULY 9, 2025

However, patients with CLL/SLL typically have a higher risk of serious infection due to their compromised immune systems, raising concerns about the association between CLL/SLL-directed therapies and serious infection risks.

Pharmacy Technician

Pharmacy Times

AUGUST 12, 2025

Eligible participants were adults (≥ 18 years) with histologically confirmed R/R DLBCL who had received 1 or more prior systemic therapy and were deemed ineligible for autologous stem cell transplantation. month follow-up was 13.5 (7.9-18.5) vs not evaluable (19.2-not not evaluable) for R-GemOx vs glofit-GemOx (HR, 0.59; P =.011),

Pharmacy Technician

Pharmacy Times

JULY 23, 2025

1 Patient Selection and Management for GLP-1 Therapy With so many GLP-1 options available, pharmacists are essential in counseling patients on available therapies based on their disease presentation, designating proper titrations and dosing schedules, and monitoring potential adverse effects.

Diabetes

Pharmacy Times

JUNE 22, 2025

1,2 Image credit: K KStock | stock.adobe.com Results revealed that the oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) lowered the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke across diverse patient populations.

Pharmacy Technician

Pharmacy Times

AUGUST 7, 2025

While RSV symptoms typically present as mild and cold-like, some individuals could develop more severe symptoms like pneumonia. Annually, an estimated 110,000 to 180,000 individuals 50 years and older are hospitalized due to RSV in the US.

Long-Term Care Facilities

Pharmacy Times

JULY 22, 2025

The Intersection of AI and Pharmacogenetics The integration of AI technologies with pharmacogenetics presents powerful opportunities for enhancing medication therapy management. Demonstrating improved outcomes and cost-effectiveness helps ensure payer support and broadens access to precision therapies.

Pharmacy Technician

Pharmacy Times

JULY 16, 2025

Community-acquired pneumonia (CAP) is a common infection caused by the inhalation of various organisms into the lower respiratory tract, which can ultimately initiate an immune and inflammatory response, potentially leading to damage to lung parenchyma.

Pharmacy Technician

PharmaTech

JUNE 9, 2025

Nanoparticles have attracted particular attention, including those based on lipids, polymers (natural and synthetic), lipid-polymer hybrids, dendrimers, inorganic materials (metals, magnetic compounds, carbon nanotubes, silica-based systems, etc.). There are also issues with targeting LNPs away from the liver, Stilwell observes.

Dosage